These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38503401)

  • 1. Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
    Wang J; Liu C; Huang SS; Wang HF; Cheng CY; Ma JS; Li RN; Lian TY; Li XM; Ma YJ; Jing ZC
    Eur J Pharmacol; 2024 May; 970():176492. PubMed ID: 38503401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
    Riou M; Enache I; Sauer F; Charles AL; Geny B
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension.
    McDowell RE; Aulak KS; Almoushref A; Melillo CA; Brauer BE; Newman JE; Tonelli AR; Dweik RA
    Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L562-L569. PubMed ID: 32022593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Warburg effect: A new story in pulmonary arterial hypertension.
    Peng H; Xiao Y; Deng X; Luo J; Hong C; Qin X
    Clin Chim Acta; 2016 Oct; 461():53-8. PubMed ID: 27475978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
    Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
    Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
    Plecitá-Hlavatá L; D'alessandro A; El Kasmi K; Li M; Zhang H; Ježek P; Stenmark KR
    Adv Exp Med Biol; 2017; 967():241-260. PubMed ID: 29047090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
    Zhou J; Li F; Yang Y
    Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
    Zhao C; Le X; Li M; Hu Y; Li X; Chen Z; Hu G; Hu L; Li Q
    Respir Res; 2023 Nov; 24(1):289. PubMed ID: 37978368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2.
    Li W; Chen W; Peng H; Xiao Z; Liu J; Zeng Y; Huang T; Song Q; Wang X; Xiao Y
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36734266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cells in Pulmonary Arterial Hypertension.
    Ni S; Ji T; Dong J; Chen F; Feng H; Zhao H; Chen D; Ma W
    Heart Lung Circ; 2022 Jul; 31(7):934-943. PubMed ID: 35361533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
    Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
    Zhu Y; Shu D; Gong X; Lu M; Feng Q; Zeng XB; Zhang H; Gao J; Guo YW; Liu L; Ma R; Zhu L; Hu Q; Ming ZY
    Hypertension; 2022 May; 79(5):932-945. PubMed ID: 35232222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.
    Hiraishi K; Kurahara LH; Ishikawa K; Go T; Yokota N; Hu Y; Fujita T; Inoue R; Hirano K
    J Smooth Muscle Res; 2022; 58(0):50-62. PubMed ID: 35944979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
    Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
    Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.
    Martin de Miguel I; Cruz-Utrilla A; Oliver E; Escribano-Subias P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
    He YZ; Wang YX; Ma JS; Li RN; Wang J; Lian TY; Zhou YP; Yang HP; Sun K; Jing ZC
    Vascul Pharmacol; 2023 Dec; 153():107216. PubMed ID: 37699495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
    Zeng C; Liu J; Zheng X; Hu X; He Y
    Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.
    Lu G; Du R; Liu Y; Zhang S; Li J; Pei J
    Vasc Health Risk Manag; 2023; 19():673-688. PubMed ID: 37881333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.